Japfa Comfeed Indonesia Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Japfa Comfeed Indonesia Tbk. trades at Rp2,030 (market cap 23.8T, 8.44M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume). The key difference: Japfa Comfeed Indonesia Tbk. is far larger — about 41.3× UBC Medical Indonesia Tbk.'s market cap, and Japfa Comfeed Indonesia Tbk. is more actively traded (8.44M versus 3.48M). Which is the better fit depends on your goals.
| JPFA | LABS | |
|---|---|---|
Market Cap | 23.8T | 576.7B |
Volume | 8.44M | 3.48M |
Lot | 84.36K | 34.82K |
Turnover | 17.08B | 522.79M |
Average Price | 2,024.41 | 150.13 |
Value | 17.08B | 522.79M |
Indicative Equilibrium Price | 2,030 | 148 |
Indicative Equilibrium Volume | 3.58K | 350 |
Trailing returns across standard periods
Latest headlines on both assets
PT Japfa Comfeed Indonesia Tbk (the Company) was established within the framework of the Foreign Capital Investment Law No. 1 year 1967 based on Notarial Deed No. 59 dated January 18, 1971 of Djojo Muljadi, S.H., public notary, as amended by Notarial Deed No. 60 dated Februari 15, 1972, of the same notary. Japfa is currently the second largest animal feed producer in Indonesia with an estimated market share of around 35% in the domestic poultry feed market. The company was originally involved in the production of copra extraction pellets
Read more on JPFA →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →